Clinical Trials Directory

Trials / Unknown

UnknownNCT01629810

Use of Whole-Body Periodic Acceleration Therapy To Aches and Pains

An Unblinded Crossover Study of The Use of Whole-Body Periodic Acceleration Therapy To Treat Pain, Stiffness, Abnormal Gait and Balance

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Center for Translational Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the effectiveness of whole body periodic acceleration for helping with symptoms of aches and pains suffered by many patients.

Detailed description

This is an unblinded cross-over study of whole-body periodic acceleration (WBPA) to ascertain if this treatment modality provides symptomatic relief of pain, stiffness, and abnormal gait and balance in a variety of conditions. The study will compare a specific mechanism of motion, whole-body periodic acceleration (WBPA), that has been shown to increase the release of beneficial mediators from the vascular endothelium into the circulation, to a control condition of slow passive motion that promotes relaxation but does not increase release of beneficial mediators into the circulation. The study tests the efficacy and safety of a commercially available device that consists of a motion platform, called Exer-Rest©, that is capable of producing both types of motion to be tested. In this investigation, 15 subjects will be randomly assigned to either procedure for 10 treatments for 2 weeks followed by a one-week "wash-out" period. Then the opposite treatment will be employed for two weeks.

Conditions

Interventions

TypeNameDescription
DEVICEWhole body periodic acceleration (Exer-Rest)Lying on the vibrating bed for 45 minutes per session for 10 sessions over 2 weeks.

Timeline

Start date
2011-08-01
Primary completion
2013-08-01
First posted
2012-06-28
Last updated
2012-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01629810. Inclusion in this directory is not an endorsement.